Canterbury DHB


September 2014

don't forget to update the issue and next review variables!!!

Changes in this release

Topic or section

Brief description


Drug Prescribing

New versions of the Standing Orders have been provided.

Jenny Roberts

Microbial Testing

Information has been added about when a terminal clean is required.

Meghan Heaphy

SCT Prescription Charts

New versions of the Conditioning documents have been provided.

Jenny Roberts


This section has been reviewed.

Mark Smith

Blood Transfusion

This section has been reviewed and updated.

Steve Gibbons

Vydia Mathavan

Veno Occlusive Disease of the Liver (VOD)

The dosage for ursodiol under Management of VOD has been changed from 300 mg to 250 mg.

Andrew Butler

CMV Prevention

The note under CMV Monitoring has been updated.

Andrew Butler

Iron Overload

This section has been reviewed and updated.

Mark Smith


This section has been reviewed and updated.

Mark Smith

Restoring Catheter Patency

The flowchart was updated so that 'alteplase' was used instead of 'Actilyse t-PA'.

Jenny Roberts

Plasma Cell Neoplasms

This section has been reviewed and updated. See the summary of changes for Plasma Cell Neoplasms

Seán MacPherson

Prescription Charts

There are new charts for the following.

Acute Lymphoblastic Leukaemia:

  • UKALL 12 Induction Phase 1
  • UKALL 12 Induction Phase 2

    Acute Myeloid Leukaemia:

  • UKAML15: MidAC

    SCT Prescription Charts:

  • Fludarabine, cytarabine, Amsacrine, and IV Busulphan
  • Fludarabine and IV Busulphan
  • Cyclophosphamide and IV Busulphan

Jenny Roberts

Heparin-induced Thrombocytopenia

A reference to Guidelines on the diagnosis and management of heparin-induced thrombocytopenia was added.

Andrew Butler

About this Canterbury DHB document (122909):

Document Owner:

Not assigned (see Who's Who)

Last Reviewed:

Next Review:


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 122909